Dr. Reddy’s Laboratories Ltd ADR (RDY)

61.30
-0.48(-0.78%)
After Hours
61.44
+0.14(+0.23%)
- Real-time Data
  • Volume:
    263,468
  • Bid/Ask
    0.00/0.00
  • Day's Range
    60.30 - 61.53

RDY Overview

Prev. Close
61.3
Day's Range
60.3 - 61.53
Revenue
2.48B
Open
60.99
52 wk Range
33.37 - 73.5
EPS
1.27
Volume
263,468
Market Cap
10.18B
Dividend (Yield)
0.28 (0.54%)
Average Volume (3m)
193,011
P/E Ratio
48.68
Beta
0.41
1-Year Change
44.54%
Shares Outstanding
165,938,865
Next Earnings Date
19 May 2021
What is your sentiment on Dr. Reddy’s Laboratories Ltd ADR?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyBuySellBuy
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellStrong Buy
SummaryStrong BuyStrong BuyBuyStrong SellStrong Buy

Dr. Reddy’s Laboratories Ltd ADR Company Profile

Dr. Reddy’s Laboratories Ltd ADR Company Profile

Employees
21650

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients and intermediates (API) or bulk drugs. Proprietary Products segment focuses on the research, development and manufacture of differentiated formulations and new chemical entities. These products fall within the dermatology and neurology therapeutic areas, and are marketed and sold through its subsidiary, Promius Pharma, LLC.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.